European Union -
English -
EMA (European Medicines Agency)
inlyta
pfizer europe ma eeig - axitinib - carcinoma, renal cell - protein kinase inhibitors - inlyta is indicated for the treatment of adult patients with advanced renal cell carcinoma (rcc) after failure of prior treatment with sunitinib or a cytokine.
Canada -
English -
Health Canada
inlyta tablet
pfizer canada ulc - axitinib - tablet - 1mg - axitinib 1mg - antineoplastic agents
Canada -
English -
Health Canada
inlyta tablet
pfizer canada ulc - axitinib - tablet - 5mg - axitinib 5mg - antineoplastic agents
Canada -
English -
Health Canada
inlyta tablet
pfizer canada ulc - axitinib - tablet - 3mg - axitinib 3mg - antineoplastic agents
Canada -
English -
Health Canada
inlyta tablet
pfizer canada ulc - axitinib - tablet - 7mg - axitinib 7mg - antineoplastic agents
Belgium -
English -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
axitinib eg 1 mg film-coat. tabl.
eg sa-nv - axitinib 1 mg - film-coated tablet - axitinib
Belgium -
English -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
axitinib eg 3 mg film-coat. tabl.
eg sa-nv - axitinib 3 mg - film-coated tablet - axitinib
Belgium -
English -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
axitinib eg 5 mg film-coat. tabl.
eg sa-nv - axitinib 5 mg - film-coated tablet - axitinib
Belgium -
English -
AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
axitinib eg 7 mg film-coat. tabl.
eg sa-nv - axitinib 7 mg - film-coated tablet - axitinib
Malta -
English -
Medicines Authority
axitinib synthon 1 mg film-coated tablets
synthon bv microweg 22, 6545 cm nijmegen, netherlands - film-coated tablet - axitinib 1 mg - antineoplastic agents